PMC:7396557 / 86816-87084 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T914","span":{"begin":168,"end":176},"obj":"SP_7"},{"id":"T92706","span":{"begin":168,"end":176},"obj":"SP_7"}],"text":"d be used within 4 h.\n\nRelevant Information on the Clinical Application of SMI\n\nRecommended Therapeutic Regimens\nSMI has been recommended in 18 therapeutic regimens of COVID-19 in China (see detailed information in Tables 1 and 2 ).\n\nIngredients of SMI\nPanax ginsen"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T527","span":{"begin":168,"end":176},"obj":"Disease"}],"attributes":[{"id":"A527","pred":"mondo_id","subj":"T527","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"d be used within 4 h.\n\nRelevant Information on the Clinical Application of SMI\n\nRecommended Therapeutic Regimens\nSMI has been recommended in 18 therapeutic regimens of COVID-19 in China (see detailed information in Tables 1 and 2 ).\n\nIngredients of SMI\nPanax ginsen"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T825","span":{"begin":117,"end":120},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T826","span":{"begin":141,"end":143},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"}],"text":"d be used within 4 h.\n\nRelevant Information on the Clinical Application of SMI\n\nRecommended Therapeutic Regimens\nSMI has been recommended in 18 therapeutic regimens of COVID-19 in China (see detailed information in Tables 1 and 2 ).\n\nIngredients of SMI\nPanax ginsen"}

{"project":"LitCovid-sentences","denotations":[{"id":"T651","span":{"begin":23,"end":78},"obj":"Sentence"},{"id":"T652","span":{"begin":80,"end":112},"obj":"Sentence"},{"id":"T653","span":{"begin":113,"end":235},"obj":"Sentence"},{"id":"T654","span":{"begin":237,"end":255},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"d be used within 4 h.\n\nRelevant Information on the Clinical Application of SMI\n\nRecommended Therapeutic Regimens\nSMI has been recommended in 18 therapeutic regimens of COVID-19 in China (see detailed information in Tables 1 and 2 ).\n\nIngredients of SMI\nPanax ginsen"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2489","span":{"begin":168,"end":176},"obj":"Disease"}],"attributes":[{"id":"A2489","pred":"tao:has_database_id","subj":"2489","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"d be used within 4 h.\n\nRelevant Information on the Clinical Application of SMI\n\nRecommended Therapeutic Regimens\nSMI has been recommended in 18 therapeutic regimens of COVID-19 in China (see detailed information in Tables 1 and 2 ).\n\nIngredients of SMI\nPanax ginsen"}